Has Ashley Sikand, MD received payments from drug or device companies?

Yes. Drug and device makers reported $284,399 in general payments to Ashley Sikand, MD across 427 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashley Sikand, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashley Sikand, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashley Sikand, MD

Otolaryngology · Henderson, NVNPI 1477519825

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $267,863 of the $284,399 with a category attached, or 94.2%. Stryker accounts for 96.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $143,302 and has fallen 99.4% since, to $926 in 2025. Among otolaryngology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$284,399in general payments, 2019–2025

Across 427 payments — averaging $666.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$274K
Acelrx Pharmaceuticals, Inc.$7K
GSK$835
Optinose US, Inc.$706
Regeneron Healthcare Solutions, Inc.$631
Sanofi$385
plus $756 from 11 others

$21,762in research payments, 2019–2025

Across 4 payments — averaging $5440.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$22K

What the payments were for

Consulting fees$267,86394%
Travel & lodging$4,9722%
Food & beverage$11,4424%
Education$1220%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	296	$273,837
Acelrx Pharmaceuticals, Inc.	5	$7,250
GSK	40	$835
Optinose US, Inc.	31	$706
Regeneron Healthcare Solutions, Inc.	23	$631
Sanofi	15	$385
Medtronic	2	$232
Acclarent, Inc	2	$127
AstraZeneca	1	$125
Sanofi-aventis U.S. LLC	1	$53
Amgen	2	$52
Inspire Medical Systems, Inc.	2	$51
Intersect ENT, Inc.	2	$47
Smith+Nephew	2	$36
Johnson & Johnson	1	$15
Phadia US Inc.	1	$13
Aerin Medical Inc.	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENTELLUS - XPRESS ENT DILATION SYSTEM$164,900
CLARIFIX CRYOTHERAPY DEVICE$90,066
XPRESS ENT DILATION SYSTEM$77,654
LATERA$51,843
SCOPIS ENT$28,574
SHAVER SYSTEM$23,644
TGS GUIDEWIRE$16,088
DSUVIA$7,250
ORTHOMAP$7,125
SPIROX - LATERA$687
ENTELLUS MEDICAL FOCESS SINUSCOPE$375
HEMOPORE$375
NASOPORE$375
DUPIXENT$364
ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$338
ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE$309
FIAGON NAVIGATION UNIT$295
NUCALA$250
FOCESS HD WIRELESS CAMERA$198
XPRESS LOPROFILE$172

How this compares

$284,399 in reported general payments places this provider in the 95th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada →

Medicare billing

Part B allowed, 2024

$782,307

Medicare patients

610

Services billed

2,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	176	$6,144
Fluticasone Propionate	217	$2,733
Ipratropium Bromide	110	$2,464
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	192	$1,409
Ofloxacin	15	$629
Methylprednisolone	66	$444
Cephalexin	24	$378
Famotidine	32	$360
Doxycycline Hyclate	44	$309
Mupirocin	38	$182
Azithromycin	48	$173
Lorazepam	124	$166
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	26	$162
Prednisone	91	$142
Tramadol Hcl	59	$119

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Henderson

Lakeisha HenryHenderson$9K
Randall WeingartenHenderson$5K
Walter SchroederHenderson$4K
Frederick GollHenderson$4K
Jonathan SalinasHenderson$1K
Timothy TolanHenderson$927
David FoggiaHenderson$366
Christopher PeersHenderson$17
Oluwafunmilola OkuyemiLas Vegas$60K
Jeannie KhavkinLas Vegas$22K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →